228 related articles for article (PubMed ID: 7501113)
21. Secondary intracranial meningiomas after high-dose cranial irradiation: report of five cases and review of the literature.
Strojan P; Popović M; Jereb B
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):65-73. PubMed ID: 10924973
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical analysis of p16INK4a, p14ARF, p18INK4c, p21CIP1, p27KIP1 and p73 expression in 271 meningiomas correlation with tumor grade and clinical outcome.
Korshunov A; Shishkina L; Golanov A
Int J Cancer; 2003 May; 104(6):728-34. PubMed ID: 12640680
[TBL] [Abstract][Full Text] [Related]
23. Proliferating cell nuclear antigen (PCNA) immunostaining as an alternative to bromodeoxyuridine (BrdU) immunostaining for brain tumours in paraffin embedded sections.
Sasaki A; Naganuma H; Kimura R; Isoe S; Nakano S; Nukui H; Suzuki K; Kawaoi A
Acta Neurochir (Wien); 1992; 117(3-4):178-81. PubMed ID: 1357920
[TBL] [Abstract][Full Text] [Related]
24. Immunostaining for proliferating cell nuclear antigen: its role in determination of proliferation in routinely processed human brain tumor specimens.
Khoshyomn S; Maier H; Morimura T; Kitz K; Budka H
Acta Neuropathol; 1993; 86(6):582-9. PubMed ID: 7906072
[TBL] [Abstract][Full Text] [Related]
25. Expression of the proliferating cell nuclear antigen and clinicopathological features in intracranial meningiomas.
Kim CH; Cheong JH; Bak KH; Kim JM; Oh SJ
J Clin Neurosci; 2001 May; 8 Suppl 1():44-8. PubMed ID: 11386825
[TBL] [Abstract][Full Text] [Related]
26. Potential doubling time and tumour doubling time in meningiomas and neurinomas.
Nakasu S; Nakasu Y; Nakajima M; Yokoyama M; Matsuda M; Handa J
Acta Neurochir (Wien); 1996; 138(6):763-70. PubMed ID: 8836295
[TBL] [Abstract][Full Text] [Related]
27. Progesterone Receptor Is Responsible for Benign Biology of Skull Base Meningioma.
Kuroi Y; Matsumoto K; Shibuya M; Kasuya H
World Neurosurg; 2018 Oct; 118():e918-e924. PubMed ID: 30031954
[TBL] [Abstract][Full Text] [Related]
28. Estrogen and progesterone receptors in human meningiomas: biochemical and immunocytochemical evaluation.
Bozzetti C; Camisa R; Nizzoli R; Manotti L; Guazzi A; Naldi N; Mazza S; Nizzoli V; Cocconi G
Surg Neurol; 1995 Mar; 43(3):230-3; discussion 234. PubMed ID: 7792684
[TBL] [Abstract][Full Text] [Related]
29. Progesterone receptors in tumor fragment spheroids of human meningiomas.
Tonn JC; Ott MM; Paulus W; Meixensberger J; Roosen K
Acta Neurochir Suppl; 1996; 65():105-7. PubMed ID: 8738509
[TBL] [Abstract][Full Text] [Related]
30. Ki-67 immunoreactivity in human central nervous system tumors: a study with MIB 1 monoclonal antibody on archival material.
Karamitopoulou E; Perentes E; Diamantis I; Maraziotis T
Acta Neuropathol; 1994; 87(1):47-54. PubMed ID: 7511316
[TBL] [Abstract][Full Text] [Related]
31. [P53 protein expression and proliferative potential in non-recurrent and recurrent meningiomas].
Miyagami M; Kanou T; Nakamura S
No To Shinkei; 1996 Aug; 48(8):719-25. PubMed ID: 8797205
[TBL] [Abstract][Full Text] [Related]
32. The significance of nucleolar organizer region (AgNOR) score in predicting meningioma recurrence.
Kunishio K; Ohmoto T; Matsuhisa T; Maeshiro T; Furuta T; Matsumoto K
Cancer; 1994 Apr; 73(8):2200-5. PubMed ID: 8156526
[TBL] [Abstract][Full Text] [Related]
33. Ki-67 staining in benign, borderline, malignant primary and metastatic ovarian tumors: correlation with steroid receptors, epidermal-growth-factor receptor and cathepsin D.
Henzen-Logmans SC; Fieret EJ; Berns EM; van der Burg ME; Klijn JG; Foekens JA
Int J Cancer; 1994 May; 57(4):468-72. PubMed ID: 8181851
[TBL] [Abstract][Full Text] [Related]
34. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections.
Cattoretti G; Becker MH; Key G; Duchrow M; Schlüter C; Galle J; Gerdes J
J Pathol; 1992 Dec; 168(4):357-63. PubMed ID: 1484317
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical study of estrogen receptor-related antigen, progesterone and estrogen receptors in human intracranial meningiomas.
Khalid H
Cancer; 1994 Jul; 74(2):679-85. PubMed ID: 8033047
[TBL] [Abstract][Full Text] [Related]
36. Growth rate of intracranial meningioma: tumor doubling time and proliferating cell nuclear antigen staining index.
Ide M; Jimbo M; Yamamoto M; Umebara Y; Hagiwara S; Kubo O
Neurol Med Chir (Tokyo); 1995 May; 35(5):289-93. PubMed ID: 7623949
[TBL] [Abstract][Full Text] [Related]
37. Progesterone receptors are detectable in tumor fragment spheroids of meningiomas in vitro.
Tonn JC; Ott MM; Meixensberger J; Paulus W; Roosen K
Anticancer Res; 1994; 14(6B):2453-6. PubMed ID: 7872666
[TBL] [Abstract][Full Text] [Related]
38. Progesterone and estrogen receptors: opposing prognostic indicators in meningiomas.
Pravdenkova S; Al-Mefty O; Sawyer J; Husain M
J Neurosurg; 2006 Aug; 105(2):163-73. PubMed ID: 17219818
[TBL] [Abstract][Full Text] [Related]
39. [Olfactory groove meningioma: correlation between clinicoradiological features and proliferative index (Mib-1)].
Paiva Neto MA; Tella OI; Herculano MA; Stávale JN; Bonatteli AP
Arq Neuropsiquiatr; 2006 Mar; 64(1):77-82. PubMed ID: 16622558
[TBL] [Abstract][Full Text] [Related]
40. The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases.
Roser F; Samii M; Ostertag H; Bellinzona M
Acta Neurochir (Wien); 2004 Jan; 146(1):37-44; discussion 44. PubMed ID: 14740263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
